There is currently no generic version of Xolair available. Do not confuse Xolair’s generic name, omalizumab, with a generic version of the drug. Xolair is classified with “biologic” drugs, which are governed by different laws and regulations than other medications.

What does Xolair do to your immune system?

Xolair is primarily used in the treatment of allergic asthma. The medication acts on the body’s immune system to prevent an allergic response to trigger such as pollen or dust mites. Xolair interferes with the cascade of events that lead to asthma symptoms.

Is there a substitute for Xolair?

A new study by researchers in AllerGen’s Clinical Investigator Collaborative (CIC) has shown that a developmental drug, QGE031 (ligelizumab), is three times more effective than Xolair (omalizumab) in reducing symptoms of mild allergic asthma.

How long does a Xolair shot last?

It may take several months before you begin to notice benefits from Xolair. However, once benefits are observed, they should last for as long as you continue to receive your regular injections. If for some reason your injections are stopped, we would expect the effects to wear off within 6 months to a year.

Does Xolair lower your immune system?

Does Xolair lower immunity? Because Xolair works on the allergic arm of the immune system, it does not appear to compromise the immune system like traditional immunosuppressants, such as prednisone and cyclosporine. Xolair is not associated with an increased risk of infection nor increase the risk for COVID-19.

Where do you inject Xolair?

XOLAIR Dosing and Frequency XOLAIR is given by an injection just under the skin (subcutaneous injection) every 4 weeks. This should be done by your healthcare provider, in a healthcare setting. XOLAIR is also available for self-injection with the prefilled syringe.

How do you qualify for Xolair?

Xolair is indicated for patients 6 years of age and older with moderate to severe persistent asthma who have a positive skin test or in vitro reactivity to a perennial aeroallergen and whose symptoms are inadequately controlled with inhaled corticosteroids.